2016 Q4 Form 10-Q Financial Statement

#000114420417010218 Filed on February 21, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2015 Q4 2015
Revenue $4.113M $4.113M $9.892M
YoY Change 0.0% 73.47% -21.35%
Cost Of Revenue $2.130M $2.800M $7.563M
YoY Change -23.93% 40.7% -22.35%
Gross Profit $1.308M $1.308M $2.328M
YoY Change 0.0% 242.2% -18.05%
Gross Profit Margin 31.81% 31.81% 23.54%
Selling, General & Admin $1.009M $1.140M $4.176M
YoY Change -11.5% 15.15% -1.78%
% of Gross Profit 77.11% 87.13% 179.35%
Research & Development $200.0K $150.0K $776.8K
YoY Change 33.33% -0.43% 31.1%
% of Gross Profit 15.29% 11.46% 33.37%
Depreciation & Amortization $0.00 $10.00K $46.07K
YoY Change -100.0% -50.0% 4.83%
% of Gross Profit 0.0% 0.76% 1.98%
Operating Expenses $1.009M $1.290M $4.952M
YoY Change -21.79% 756.28% 2.24%
Operating Profit $299.5K $18.37K -$2.624M
YoY Change 1530.57% -102.41% 31.03%
Interest Expense $20.34K -$190.0K -$1.129M
YoY Change -110.7% -44.12% 706.11%
% of Operating Profit 6.79% -1034.41%
Other Income/Expense, Net -$20.34K -$7.135K $22.83K
YoY Change 185.05%
Pretax Income -$550.0K -$7.135K -$3.730M
YoY Change 7608.48% -219.75% 74.35%
Income Tax -$25.00K
% Of Pretax Income
Net Earnings -$174.2K -$174.2K $3.705M
YoY Change 0.0% -84.19% -16.75%
Net Earnings / Revenue -4.23% -4.23% 37.46%
Basic Earnings Per Share
Diluted Earnings Per Share -$238.1K -$73.59K -$1.602M
COMMON SHARES
Basic Shares Outstanding 2.313M shares
Diluted Shares Outstanding 2.313M shares

Balance Sheet

Concept 2016 Q4 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $160.0K $230.0K $49.43K
YoY Change -30.43% -83.33% -97.59%
Cash & Equivalents $155.8K $227.1K
Short-Term Investments
Other Short-Term Assets $200.0K $210.0K $1.071M
YoY Change -4.76% -8.7% 161.14%
Inventory $5.560M $4.597M $3.852M
Prepaid Expenses $212.5K
Receivables $250.0K $202.6K $517.0K
Other Receivables $1.280M $2.640M $1.271M
Total Short-Term Assets $7.450M $7.977M $6.761M
YoY Change -6.61% 16.29% -24.38%
LONG-TERM ASSETS
Property, Plant & Equipment $53.11K $79.82K $104.6K
YoY Change -33.46% -27.44% -30.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.61M $12.08M $12.94M
YoY Change -12.18% -10.9% -8.46%
Other Assets $0.00 $6.000K $26.00K
YoY Change -100.0% -85.0% -35.0%
Total Long-Term Assets $10.73M $12.23M $13.15M
YoY Change -12.28% -11.23% -8.71%
TOTAL ASSETS
Total Short-Term Assets $7.450M $7.977M $6.761M
Total Long-Term Assets $10.73M $12.23M $13.15M
Total Assets $18.18M $20.21M $19.91M
YoY Change -10.04% -2.08% -14.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.540M $423.2K $968.8K
YoY Change 500.15% -47.1% 51.38%
Accrued Expenses $120.0K $300.0K $180.2K
YoY Change -60.0% 36.36% 20.13%
Deferred Revenue
YoY Change
Short-Term Debt $690.0K $1.630M $0.00
YoY Change -57.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.350M $3.226M $1.149M
YoY Change 3.84% 213.21% 45.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.350M $3.226M $1.149M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.350M $3.230M $1.149M
YoY Change 3.72% 207.62% 41.86%
SHAREHOLDERS EQUITY
Retained Earnings $3.226M
YoY Change
Common Stock $12.89M $12.91M
YoY Change -0.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.83M $16.99M $18.76M
YoY Change
Total Liabilities & Shareholders Equity $18.18M $20.21M $19.91M
YoY Change -10.06% -2.07% -14.71%

Cashflow Statement

Concept 2016 Q4 2015 Q4 2015
OPERATING ACTIVITIES
Net Income -$174.2K -$174.2K $3.705M
YoY Change 0.0% -84.19% -16.75%
Depreciation, Depletion And Amortization $0.00 $10.00K $46.07K
YoY Change -100.0% -50.0% 4.83%
Cash From Operating Activities -$120.0K -$740.0K -$1.370M
YoY Change -83.78% -47.52% 60.77%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $100.0K $820.0K -$631.9K
YoY Change -87.8% -250.45%
Cash From Investing Activities $100.0K $820.0K -$631.9K
YoY Change -87.8% -265.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K 630.0K $0.00
YoY Change -95.24% -100.0%
NET CHANGE
Cash From Operating Activities -120.0K -740.0K -$1.370M
Cash From Investing Activities 100.0K 820.0K -$631.9K
Cash From Financing Activities 30.00K 630.0K $0.00
Net Change In Cash 10.00K 710.0K -$2.002M
YoY Change -98.59% -150.35% 416.0%
FREE CASH FLOW
Cash From Operating Activities -$120.0K -$740.0K -$1.370M
Capital Expenditures $0.00
Free Cash Flow -$1.370M
YoY Change 67.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
1151723 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
362728 USD
CY2016Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
693766 USD
CY2016Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20338 USD
CY2015Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7135 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-49123 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20118 USD
CY2015Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-268350 USD
CY2015Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-281316 USD
CY2016Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-799681 USD
CY2016Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-180486 USD
CY2016Q4 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-69389 USD
uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-398177 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841 USD
CY2016Q1 uuu Commissions And Other
CommissionsAndOther
74327 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
51188 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63722 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71556 USD
CY2016Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
67075 USD
CY2016Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10610725 USD
us-gaap Gross Profit
GrossProfit
3358390 USD
us-gaap Net Income Loss
NetIncomeLoss
-1362552 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53112 USD
CY2016Q4 uuu Commissions And Other
CommissionsAndOther
65630 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155826 USD
uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
7231947 USD
uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
6949332 USD
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
220224 USD
uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
262222 USD
us-gaap Gross Profit
GrossProfit
2875451 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1078904 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-438711 USD
us-gaap Net Income Loss
NetIncomeLoss
-1003551 USD
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841 USD
CY2016Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
313891 USD
CY2016Q4 us-gaap Assets
Assets
18181061 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-515717 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-263530 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.59
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2312887 shares
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3277480 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3459284 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
519621 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
495071 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1554191 USD
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312887 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
uuu Proceeds From Cash Distributions From Joint Venture
ProceedsFromCashDistributionsFromJointVenture
102581 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2272870 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-689358 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1628214 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
379875 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
499057 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1466836 USD
uuu Increase Decrease In Funds Held By Factor
IncreaseDecreaseInFundsHeldByFactor
0 USD
uuu Increase Decrease In Funds Held By Factor
IncreaseDecreaseInFundsHeldByFactor
631906 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
102581 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
822367 USD
CY2016Q1 uuu Working Capital
WorkingCapital
4463601 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
2137792 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
3704985 USD
CY2016Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1783000 USD
CY2016Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
1767000 USD
CY2016Q4 us-gaap Line Of Credit
LineOfCredit
693766 USD
CY2016Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
4352661 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
5079527 USD
CY2016Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
3878625 USD
CY2016Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
25825609 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
29543358 USD
CY2016Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
13136416 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
10689736 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-782051 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-359513 USD
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
2169453 USD
us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
2779556 USD
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
13271177 USD
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
15002160 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2016Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
312920 USD
CY2016Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
139985 USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
uuu Proceeds From Cash Distributions From Joint Venture
ProceedsFromCashDistributionsFromJointVenture
190461 USD
us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
The Agreement for the assignment of accounts receivable expires on January 6, 2018 and provides for continuation of the program on successive two year periods until terminated by one of the parties to the Agreement. In accordance with the provisions of the Agreement, the Company may take advances equal to eighty percent (80%) of the uncollected non-recourse factored trade accounts receivable balance less applicable factoring commissions and may borrow up to fifty percent (50%) of eligible inventories subject to a borrowing limitation on inventory of $1,000,000.
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
bear interest at the prime commercial rate of interest, as published, plus two percent (Effective rate 5.50% at December 31, 2016).
uuu Accounts Receivables Factoring Agreement Term
AccountsReceivablesFactoringAgreementTerm
P2Y
uuu Accounts Receivables Factoring Agreement Expiration Date
AccountsReceivablesFactoringAgreementExpirationDate
2018-01-06
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2016Q4 uuu Working Capital
WorkingCapital
4102145 USD
uuu Increase Decrease In Working Capital
IncreaseDecreaseInWorkingCapital
361456 USD

Files In Submission

Name View Source Status
0001144204-17-010218-index-headers.html Edgar Link pending
0001144204-17-010218-index.html Edgar Link pending
0001144204-17-010218.txt Edgar Link pending
0001144204-17-010218-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logo_ex99-1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uuu-20161231.xml Edgar Link completed
uuu-20161231.xsd Edgar Link pending
uuu-20161231_cal.xml Edgar Link unprocessable
uuu-20161231_def.xml Edgar Link unprocessable
uuu-20161231_lab.xml Edgar Link unprocessable
uuu-20161231_pre.xml Edgar Link unprocessable
v457105_10q.htm Edgar Link pending
v457105_ex31-1.htm Edgar Link pending
v457105_ex31-2.htm Edgar Link pending
v457105_ex32-1.htm Edgar Link pending
v457105_ex99-1.htm Edgar Link pending